Literature DB >> 14824395

Relationship between serum antibodies and subclinical infections with poliomyelitis virus.

G C BROWN, J D AINSLIE.   

Abstract

Three families in which cases of poliomyelitis had recently occurred were studied for the extent of subclinical infection and the presence of serum antibodies to both the mouse-adapted Lansing strain and the specific strain of poliomyelitis isolated from members of the family. Virus was recovered from the stools of all 5 cases and from 8 of 17 familial associates at the time of the first collection of specimens. Only two of the associates were still carrying virus 3 weeks later. The individuals from whom virus was recovered were younger than 11 years of age with two exceptions, one of them a frank case. Antibodies to the mouse-adapted Lansing strain of poliomyelitis virus were demonstrated in the sera of every person 11 years of age or older but in none from individuals under this age with the possible exception of one whose second specimen was weakly positive. Antibodies for the specific agent isolated from each family were likewise found at the beginning of the study in every person over 11 years of age but also in 4 of 9 under that age. The neutralization indices of sera of the second collection were generally higher than those of the sera collected soon after the disease occurred in the family, reflecting the antigenic stimulus of the "family" viruses. The inverse relationship of demonstrable antibodies to virus isolations strongly suggests that the presence of serum antibodies is effective in limiting subclinical infection with poliomyelitis virus. The question of cross-immunity in protection against infection with poliomyelitis virus is discussed.

Entities:  

Keywords:  POLIOMYELITIS

Mesh:

Substances:

Year:  1951        PMID: 14824395      PMCID: PMC2136087          DOI: 10.1084/jem.93.3.197

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  NEUTRALIZATION TESTS IN POLIOMYELITIS. SERA TAKEN DURING THE ACUTE AND CONVALESCENT STAGES OF THE DISEASE AND TESTED WITH A PASSAGE VIRUS AND A STRAIN ISOLATED DURING THE 1935 NEW YORK CITY OUTBREAK.

Authors:  M Brodie; A E Fischer; M Stillerman
Journal:  J Clin Invest       Date:  1937-05       Impact factor: 14.808

2.  THE ISOLATION OF POLIOMYELITIS VIRUS FROM HUMAN EXTRA-NEURAL SOURCES. II. COMPARISON OF VIRUS CONTENT OF BLOOD, OROPHARYNGEAL WASHINGS, AND STOOLS OF CONTACTS.

Authors:  J L Melnick; D M Horstmann; R Ward
Journal:  J Clin Invest       Date:  1946-03       Impact factor: 14.808

3.  Poliomyelitis in families attacked by the disease; distribution of virus in stool and oropharynx of members in households.

Authors:  H A WENNER; W A TANNER
Journal:  Am J Med Sci       Date:  1948-09       Impact factor: 2.378

4.  Serum neutralizing antibodies to the infecting strain of virus in poliomyelitis patients.

Authors:  W M HAMMON; E C ROBERTS
Journal:  Proc Soc Exp Biol Med       Date:  1948-11

5.  STUDIES OF THE DISTRIBUTION OF POLIOMYELITIS VIRUS : V. THE VIRUS IN FAMILIAL ASSOCIATES OF CASES.

Authors:  G C Brown; T Francis; J Ainslie
Journal:  J Exp Med       Date:  1948-01-01       Impact factor: 14.307

6.  Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract.

Authors:  A J STEIGMAN; A B SABIN
Journal:  J Exp Med       Date:  1949-10       Impact factor: 14.307

7.  OCCURRENCE OF POLIOMYELITIS VIRUS IN AUTOPSIES, PATIENTS, AND CONTACTS.

Authors:  J F Kessel; F J Moore; F D Stimpert; R T Fisk
Journal:  J Exp Med       Date:  1941-11-30       Impact factor: 14.307

8.  NEUTRALIZING ANTIBODIES IN ABORTIVE POLIOMYELITIS.

Authors:  J D Trask; J R Paul
Journal:  J Exp Med       Date:  1933-10-31       Impact factor: 14.307

  8 in total
  5 in total

1.  The development of homologous neutralizing antibody during a type 1 poliomyelitis epidemic.

Authors:  J A MILES; F J AUSTIN; J E CAUGHEY
Journal:  J Hyg (Lond)       Date:  1958-09

2.  Influence of vaccination with formalin inactivated vaccine upon gastrointestinal infection with polioviruses.

Authors:  M L LEPOW; F C ROBBINS; W A WOODS
Journal:  Am J Public Health Nations Health       Date:  1960-04

3.  The incidence of infection among contacts of poliomyelitis cases.

Authors:  D M HORSTMANN; R W MCCOLLUM; A D MASCOLA
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808

4.  Viremia in human poliomyelitis.

Authors:  D M HORSTMANN; R W McCOLLUM; A D MASCOLA
Journal:  J Exp Med       Date:  1954-04-01       Impact factor: 14.307

5.  Isolation of antigen-binding cells from unprimed mice: demonstration of antibody-forming cell precursor activity and correlation between precursor and secreted antibody avidities.

Authors:  M H Julius; L A Herzenberg
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.